Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome-A Late, but Wise Decision

Rev Bras Ginecol Obstet. 2019 Mar;41(3):137-141. doi: 10.1055/s-0039-1685482. Epub 2019 Apr 16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adult
  • Decision Making
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance*
  • Polycystic Ovary Syndrome / drug therapy*
  • Randomized Controlled Trials as Topic
  • Women's Health
  • Young Adult

Substances

  • Hypoglycemic Agents